Olaparib

Dorne chemical technology co. LTD

Olaparib is a targeted cancer therapy known as a PARP (poly ADP-ribose polymerase) inhibitor. It is used to treat certain types of cancers, particularly those with BRCA1 or BRCA2 gene mutations, such as ovarian, breast, and pancreatic cancers. Olaparib works by blocking the PARP enzyme, which is involved in repairing DNA damage in cancer cells. By inhibiting this repair mechanism, olaparib induces the accumulation of DNA damage in cancer cells, leading to cell death and reducing tumor growth. Dorne chemical technology co. LTD is a comprehensive chemical enterprise integrating r&d, production and sales. It is a leading manufacturer and supplier of chemical products in China.We develop, produce and market high quality pharmaceuticals, intermediates, specialty chemicals and OLED intermediates, as well as other fine chemicals.Relying on the laboratory and taking the factory as the base, the company has the whole process ability of fine chemical product research and development, production and processing, testing and packaging to export.We have a research team of excellent engineers, professional technical personnel dedicated to the research and development of new products, in addition, we are also committed to industry and academia to provide customized synthetic research services.The company adheres to the quality control and quality assurance system based on ISO standards. QA and QC are applied to the whole process of raw material control, production process control and finished product quality inspection.To provide customers with high quality products and services is our business philosophy!